SAN DIEGO & DUBLIN--(BUSINESS WIRE)--Crown Bioscience, Inc, a JSR Life Sciences Company, and ERS Genomics Limited (‘ERS’) have signed a global license agreement for access to the foundational ...
Crown Bioscience inked a licensing deal with ERS Genomics to use its CRISPR/Cas9 patent portfolio for gene editing in the development of new treatments in the fields of oncology, immuno-oncology and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback